The China Biologic Products Inc (CBPO) Sees Large Growth in Short Interest

The China Biologic Products Inc (CBPO) Sees Large Growth in Short Interest

In other news, insider Zhijing Cbpo Liu sold 7,500 shares of China Biologic Products stock in a transaction that occurred on Tuesday, May 9th. The shares were sold at an average price of $116.49, for a total value of $873,675.00. Following the transaction, the insider now directly owns 10,969 shares of the company’s stock, valued at $1,277,778.81. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.68% of the company’s stock.

China Biologic Products Inc (NASDAQ:CBPO) was the target of a significant increase in short interest in April. As of April 28th, there was short interest totalling 1,801,192 shares, an increase of 6.5% from the April 13th total of 1,690,750 shares. Based on an average trading volume of 212,352 shares, the short-interest ratio is presently 8.5 days.

A number of institutional investors have recently bought and sold shares of the company. Dumac Inc. acquired a new stake in shares of China Biologic Products during the fourth quarter worth $100,000. Oppenheimer Asset Management Inc. acquired a new stake in shares of China Biologic Products during the first quarter worth $156,000. Eqis Capital Management Inc. raised its stake in shares of China Biologic Products by 51.3% in the first quarter. Eqis Capital Management Inc. now owns 3,220 shares of the biopharmaceutical company’s stock worth $322,000 after buying an additional 1,092 shares in the last quarter. Trexquant Investment LP acquired a new stake in shares of China Biologic Products during the fourth quarter worth $462,000. Finally, Nomura Holdings Inc. acquired a new stake in shares of China Biologic Products during the first quarter worth $463,000. Institutional investors and hedge funds own 69.86% of the company’s stock. Shares of China Biologic Products (NASDAQ:CBPO) opened at 114.28 on Monday. China Biologic Products has a one year low of $96.99 and a one year high of $137.38. The company has a market cap of $3.11 billion, a price-to-earnings ratio of 29.60 and a beta of 1.78. The firm has a 50-day moving average of $114.59 and a 200 day moving average of $110.34.

About China Biologic Products China Biologic Products, Inc (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:CBPO”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for China Biologic Products Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for China Biologic Products Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment